Working with a company

A company approaches you or you wish to approach a company. Contact the Inserm Transfert teams as soon as possible, in order that they can assist you and take over correspondence with the company for you.

Involving companies

You interact with a company

In both situations, be careful not to divulge any information until a confidentiality agreement has been signed with the company. Contact the Inserm Transfert teams as soon as possible, so that they can help you to identify confidential information and take the lead in conversations with industrialists in order to set up this agreement, which must be signed by a legal representative of Inserm.

We remind you that no laboratory staff are trained to commit the laboratory to third parties or the private sector subject to liability. All official documents must be signed by the competent administration.

Contact

Inserm Transfert

Legal Affairs Department

cda@inserm-transfert.fr

Industrial collaborations: What is a contract for? What needs to be known and what are the differences between the contracts?

The contractual arrangements with an industrial partner vary depending on the project. Inserm Transfert considers three main situations :
  • The use of a patent, know-how, or proprietary biological material through the setting up of the license agreement;
  • Setting up a collaborative agreement between an academic team and a company for a given project; where applicable, combined with a license agreement;
  • An approach involving establishment of customized long term partnerships with companies (generally middle size companies or large groups), based on specific identification of the company’s needs and linked to the specific expertise of the teams and/or high potential value patents on the subjects in question.
These contracts govern the relationship which you and your team will have with the industrial partner, fixing the type of agreement, collaboration methods and access to intellectual property (patents, know-how, biological materials), the scientific programme, ownership of the results which are obtained from it and the funding conditions. The written contract formalizes a discussion which determines the funding of the research programme and sets the financial returns from use of the patents, know-how and biological materials involved.

Other contracts govern:

  • An exchange of information for assessment: this is thenceforth a confidentiality agreement (or CDA for Confidential Disclosure Agreement);
  • An exchange of material: this is a material transfer agreement (or MTA for Material Transfer Agreement).
N.B: Inserm Transfert is involved only if at least one of your partners is an industrialist. If you have any questions, you can also contact your Regional Delegation.

Contact

Inserm Transfert

Mireille Caralp

donnees.sante@inserm-transfert.fr

Inserm Transfert

Noémie Pellegrin

noemie.pellegrin@inserm-transfert.fr

Inserm Transfert

Olivier Bignolais

R.D.Partnership@inserm-transfert.fr

Inserm Transfert

Pascale Augé

pascale.auge@inserm-transfert.fr